|
|
|
|
|
Monday, 24 July 2006 09:58 | BNN: British Nursing News Online · www.bnn-online.co.uk
|
|
Thousands of women with early breast cancer could get life-saving treatment with the official recommendation today that Taxotere should be given to patients after surgery.
Taxotere, a chemotherapy drug already given to women with late-stage breast cancer, will be given to certain women in the early stages of the disease, under draft guidance to be issued today by the government's drugs watchdog, the National Institute for Health and Clinical Excellence (Nice).
The guidance comes nine months after the Scottish equivalent of Nice, the Scottish Medicines Consortium, approved the use of Taxotere for Scottish women in the early stages of the disease.
David Miles, consultant oncologist at London Bridge hospital, said: "If Taxotere is routinely available in the UK it has the potential to prevent the deaths of hundreds of women with breast cancer each year.
"We welcome this landmark [ruling] from Nice, which represents an important step forward for the treatment of early stage breast cancer in the UK. Results from numerous clinical trials confirm that Taxotere-containing regimens are the foundation for effective treatment strategies at every stage of breast cancer”.
The guidance is still open to consultation, but the final version is not expected to be changed when it is published next month.
|
|
-
0 comments on this story
|
|
Home Top Disclaimer Site
Credits
Nursing Jobs | Just for Nurses | Nursing Agencies List | Charles Bloe Training
Nursing Portal | Nursing Events | Brutish Nursing | British Nursing Websites
Website Development and SEO Services
|
|
|